approval
savePRALUENT (ALIROCUMAB) — FDA approval
community read0 votes
Sponsor: REGENERON PHARMACEUTICALS. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalPRALUENT (ALIROCUMAB) — FDA approvalOct 9, 2025 · 361d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalMar 8, 2024 · 941d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalApr 1, 2021 · 2013d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalMar 10, 2020 · 2400d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalApr 26, 2019 · 2719d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalApr 26, 2019 · 2719d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalNov 6, 2018 · 2890d ago
- approvalPRALUENT (ALIROCUMAB) — FDA approvalAug 22, 2018 · 2966d ago
same company · ±60 days · 5
- approvalalirocumab: PRALUENT (ALIROCUMAB) — FDA approvalApr 1, 2021
- approvalcemiplimab: LIBTAYO (CEMIPLIMAB-RWLC) — FDA approvalFeb 22, 2021
- approvalevinacumab: EVKEEZA (EVINACUMAB-DGNB) — FDA approvalFeb 11, 2021
- approvalcemiplimab: LIBTAYO (CEMIPLIMAB-RWLC) — FDA approvalFeb 9, 2021
- approvalcemiplimab: LIBTAYO (CEMIPLIMAB-RWLC) — FDA approvalFeb 9, 2021
comments(0)
5-min edit window · permanent after that